subscribeSubscribe
NICE says yes to GSK`s Cabenuva, new option for HIV patients

NICE says yes to GSK`s Cabenuva, new option for HIV patients
K. Dunleavy FIERCEPHARMA
19 Nov 2021
Share Share
ViiV sees first global approval of Cabenuva in Canada

ViiV sees first global approval of Cabenuva in Canada
Anna Smith PHARMATIMES
23 Mar 2020
Share Share
FDA Confirms Paragraph IV Patent Challenge of Odefsey 208351 (Emtricitabine, Rilpivirine Hydrochloride and Tenofovir Alafenamide Fumarate )Tablets

FDA Confirms Paragraph IV Patent Challenge of Odefsey 208351 (Emtricitabine, Rilpivirine Hydrochloride and Tenofovir Alafenamide Fumarate )Tablets

FDA
07 Jan 2020
Share Share
FDA slams GSK`s monthly HIV injectable with CRL, citing manufacturing issues

FDA slams GSK`s monthly HIV injectable with CRL, citing manufacturing issues
Amber Tong ENDPTS
24 Dec 2019
Share Share
J&J-backed AIDS film picked up by Verizon Media

J&J-backed AIDS film picked up by Verizon Media
Beth Snyder Bulik FIERCE PHARMA
10 May 2019
Share Share
Prescription med: new or extended uses, new combinations of registered medicines

Prescription med: new or extended uses, new combinations of registered medicines
TGA
09 Jul 2018
Share Share
Fresh off its Juluca approval, GSK beefs up trials of long-acting HIV duo

Fresh off its Juluca approval, GSK beefs up trials of long-acting HIV duo
Carly Helfand FIERCE PHARMA
28 Nov 2017
Share Share
ViiV’s long-acting two-drug HIV regimen hits targets

ViiV’s long-acting two-drug HIV regimen hits targets
Selina McKee PHARMA TIMES
25 Jul 2017
Share Share
With two-drug combo data, GSK primes for an HIV market-share steal

With two-drug combo data, GSK primes for an HIV market-share steal
Arlene Weintraub FIERCE PHARMA
15 Feb 2017
Share Share
Gilead`s latest HIV cocktail wins FDA approval with a blockbuster pedigree

Gilead`s latest HIV cocktail wins FDA approval with a blockbuster pedigree
Damian Garde FIERCE BIOTECH
01 Mar 2016
Share Share